Myocardial Survival Signaling in Response to Stem Cell Transplantation

Journal of the American College of Surgeons

Volumn 208, Issue 4, 2009, Pages 607-613

  Li, Hongzhe ^a,b   Malhotra, Deepak ^a,b   Yeh, Che chung ^a,b   Tu, Richard ^a,b   Zhu, Bo Qing ^a,b   Birger, Noy ^a,b   Wisneski, Andrew ^a,b   Cha, John ^a,b   Karliner, Joel S ^a,b   Mann, Michael J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVATION; ENZYME REGULATION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

ANIMALS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION, LEFT;

EID: 62349135106     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2008.12.016     Document Type: Article

References (43)

1. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
2. Tomita S., Li R.K., Weisel R.D., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100 (1999) II247-II256
3. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
4. Levenberg S., Golub J.S., Amit M., et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 99 (2002) 4391
5. Miyahara Y., Nagaya N., Kataoka M., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12 (2006) 459-465
6. Behfar A., Zingman L.V., Hodgson D.M., et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 16 (2002) 1558-1566
7. Dai W., Hale S.L., Martin B.J., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112 (2005) 214-223
8. Kofidis T., de Bruin J.L., Yamane T., et al. Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation 111 (2005) 2486-2493
9. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
10. Niagara M.I., Haider H.K., Jiang S., et al. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100 (2007) 545-555
11. Burchfield J., Iwasaki M., Koyanagi M., et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection following myocardial infarction. Circ Res 103 (2008) 203-211
12. Baines C.P., and Molkentin J.D. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 38 (2005) 47-62
13. Morissette M.R., and Rosenzweig A. Targeting survival signaling in heart failure. Curr Opin Pharmacol 5 (2005) 165-170
14. Takemura G., and Fujiwara H. Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 10 (2006) 56-75
15. McMullen J.R., Shioi T., Zhang L., et al. Phosphoinositide 3-kinase(p110{alpha}) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A 100 (2003) 12355-12360
16. Bueno O.F., De Windt L.J., Tymitz K.M., et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19 (2000) 6341-6350
17. Shiojima I., Sato K., Izumiya Y., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115 (2005) 210-218
18. Doukas J., Wrasidlo W., Noronha G., et al. Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. Proc Natl Acad Sci U S A 103 (2006) 19866-19871
19. Wang Y., Huang S., Sah V.P., et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273 (1998) 2161-2168
20. Liao P., Georgakopoulos D., Kovacs A., et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci U S A 98 (2001) 283-288
21. Zhang S., Weinheimer C., Courtois M., et al. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. AJ. J Clin Invest 111 (2003) 833-841
22. Mazhari R., and Hare J.M. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 4 Suppl 1 (2007) S21-S26
23. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
24. Murry C.E., Soonpaa J.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
25. Guide for the Care and Use of Laboratory Animals. Bethesda, MD: US National Institutes of Health. NIH Publication No. 85 to 23, revised 1996.
26. Peister A., Mellad J.A., Larson B.L., et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103 (2004) 1662-1668
27. Tang Y.L., Zhao Q., Zhang Y.C., et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117 (2004) 3-10
28. Foncea R., Galvez A., Perez V., et al. Extracellular regulated kinase, but not protein kinase C, is an antiapoptotic signal of insulin-like growth factor-1 on cultured cardiac myocytes. Biochem Biophys Res Commun 273 (2000) 736-744
29. Rubart M., Pasumarthi K.B., Nakajima H., et al. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res 92 (2003) 1217-1224
30. Noiseux N., Gnecchi M., Lopez-Ilasaca M., et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14 (2006) 840-850
31. Andrade J., Lam J.T., Zamora M., et al. Predominant fusion of bone marrow-derived cardiomyocytes. Cardiovasc Res 68 (2005) 387-393
32. Rodrigo M.C., Swigart P.M., Myagmar B.-E., et al. Beta-blockers switch catecholamine activation of MAPKs from Maladaptive beta-adrenergic-p38 to adaptive alpha-1-adrenergic-ERK. Circulation 114 (2006) II-101
33. Spyridopoulos I., Erben Y., Brummendorf T.H., et al. Telomere gap between granulocytes and lymphocytes is a determinant for haematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arterioscler Thromb Vasc Biol 28 (2008) 968-974
34. Janzen V., Forkert R., Fleming H.E., et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443 (2006) 421-426
35. Urbanek K., Torella D., Sheikh F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A 102 (2005) 8692-8697
36. van Weel V., Seghers L., de Vries M.R., et al. Expression of vascular endothelial growth factor, stromal cell-derived factor-1, and CXCR4 in human limb muscle with acute and chronic ischemia. Arterioscler Thromb Vasc Biol 27 (2007) 1426-1432
37. Chang E.I., Loh S.A., Ceradini D.J., et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 116 (2007) 2818-2829
38. Kissel C.K., Lehmann R., Assmus B., et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 49 (2007) 2341-2349
39. Tokalov S.V., Gruner S., Schindler S., et al. Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells Dev 16 (2007) 439-446 a
40. Dimmeler S., and Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 102 (2008) 1319-1330
41. Pfeiffer P., Müller P., Kazakov A., et al. Time-dependent cardiac chimerism in gender-mismatched heart transplantation patients. J Am Coll Cardiol 48 (2006) 843-845
42. Ogawa R., Mizuno H., Watanabe A., et al. Adipogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice-including relationship of sex differences. Biochem Biophys Res Commun 319 (2004) 511-557
43. Guerra S., Leri A., Wang X., et al. Myocyte death in the failing human heart is gender dependent. Circ Res 85 (1999) 856-866